In the ever-volatile world of biotech investing, few names have been as reliable or as steady as UnitedHealth Group (NYSE: UNH). The healthcare insurance titan has consistently delivered healthy returns to its investors, but the tides seem to have turned in 2025. A startling 38% sell-off in shares has not only made UnitedHealth one of […]